Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth <i>in vivo</i>
Haoyu Li(Central South University), Jianhua Yang(Children's National)
Cited by 23
Related Papers
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
|Protein & Cell|2013|767
A Strategy for Modulation of Enzymes in the Ubiquitin System
|Science|2013|296
Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6‐Methyladenosine mRNA Methylation‐Dependent Mechanism
|Hepatology|2021|134
Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop Is Required for Interleukin (IL)-1-mediated Optimal NFκB and AP-1 Activation as Well as IL-6 Gene Expression
|Journal of Biological Chemistry|2008|112
Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
|Scientific Reports|2016|80